Clearikon Health Introduces Innovative Wound Care Solutions
Clearikon Health, a UF Innovate | Accelerate alumni company, continues to revolutionize equine healthcare with the launch of innovative wound care products.
University of Florida Engineers Develop New Protocol To Purify DNA
UF researchers have developed a microfluidic device for DNA purification that could speed up analysis of laboratory samples and match or exceed the purity of existing methods.
UF College of Medicine Launches Pediatric Obesity Fellowship To Tackle National Epidemic
UF’s Pediatric Obesity Fellowship Training Program is paving the way for specialized training to address the growing need for obesity prevention and treatment.
Three UF Faculty Members Honored With Presidential Early Career Award for Scientists and Engineers
Three UF researchers have received the Presidential Early Career Award for Scientists and Engineers (PECASE), one of the highest honors awarded to scientists by the U.S. government.
Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing
UF startup Cannabix Technologies announced it has entered into an MOU with AlcoPro to collaborate on marketing efforts for the Cannabix Marijuana Breathalyzer in the U.S.
UF/IFAS Researchers Deploy Drones To Perfect Nutrient Rates
UF researchers have used drones to develop algorithms that estimate nutrient application rates for optimal crop yields.
UF Study of Deadly Dog Cancer Reveals New Clues for Improved Treatment
UF researchers have identified a crucial link between a gene mutation and immune system signaling in canine hemangiosarcoma, a discovery that could lead to better treatments for both dogs and humans with similar cancers.
Tech Tuesday: StartGNV Hosts Upcoming CelebrateGNV Event That Celebrates Local Entrepreneurs
In this week’s Tech Tuesday, UF Innovate’s host Bethany Gaffey introduces Scott Schroeder from StartGNV, an organization dedicated to supporting the entrepreneurial ecosystem in North Central Florida and hosting the upcoming CelebrateGNV event on February 6th.
Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia
Solid Biosciences Inc., a life sciences company that acquired UF startup AavantiBio, announced that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for SGT-212, the Company’s, AAV-based gene therapy candidate for the treatment of Friedreich’s ataxia (FA).
UF Researchers Leverage AI To Predict Factors Influencing Lung Disease
UF researchers may leverage AI to uncover measurements that predict the initial tipping point of lung function decline in chronic obstructive pulmonary disease.